Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Lilly Announces Acquisition of Protomer Technologies
Eli Lilly and Company (NYSE: LLY) today announced the acquisition of Protomer Technologies (“Protomer”), a private […]
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market
A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]
NHS Investment Boost to Ambulance Staff Numbers Ahead of Winter
Ambulance Trusts in England will be given an extra £55 million to boost staff numbers […]
Intuitap Medical's Disruptive Spinal Tap Technology Enters Clinical Trials as they Close Successful $5.5m Series a Round of Funding Led by the Pink Ceiling and Curate Capital
IntuiTap Medical, a cutting-edge medical device company with technology poised to change the spinal tap, […]
New Mega Laboratory Opens to Bolster Fight Against COVID-19
The UK’s first testing megalab – the Rosalind Franklin laboratory in Royal Leamington Spa has […]
‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis
‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]
Stem Cell Therapy Company Amniotics Raises SEK 60 Million
Amniotics AB (publ) (“Amniotics” or the “Company”), a stem cell therapy company has raised SEK60 million through […]
10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that Fosun Industrial Co., Limited (“Fosun Industrial”), […]
You Can Now Access an Online Doctor with Boots
Boots UK has launched Online Doctor services for 45 healthcare conditions – from skin conditions […]
IW Capital Announces Investment in E-Pharmacy Platform SimplyMeds
IW Capital is proud to announce their investment in e-pharmacy company SimplyMeds, marking the first external investment in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more